As of 10:31 AM on the 3rd, Celltrion is trading at 304,000 KRW, down 1.46% from the previous day. This represents an 18.75% increase compared to June 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 31,347 shares of Celltrion, and institutions have net sold 12,000 shares, according to provisional data. Over the past five days, individual investors have net sold 6,496 shares, while foreigners and institutions have net bought 165,130 shares and net sold 141,413 shares, respectively.

On June 29, Celltrion was a market topic with the news of the recommendation for European approval of 'Remsima SC,' leading to a 'strong performance.'



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing